Mapping the effectiveness and risks of GLP-1 receptor agonists - Nature.com

Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature.comDo GLP-1 drugs have health risks beyond their weight loss benefits?  Medical News TodayDiabetes and Obesity Drugs Study Points to Effectiveness in Curbing Addictions  BloombergMassive new study finds drugs like Ozempic affect 175 conditions — including a few surprises  New York Post